We performed a series of studies to examine the sequential development of nephritis during murine malaria infections and to define the role of DNA-binding antibodies in the associated pathology. Serum levels of these antibodies were assessed throughout acute and chronic malaria infections. Increased levels of double-stranded DNA-and single-stranded DNA-binding antibodies were initially detected in mice infected with Plasmodium vinckei or Plasmodium yoelii nigeriensis during the middle stages of infection, and these levels were maintained until death. Infection with the more chronic organism Plasmodium berghei clone RC also resulted in increased single-stranded DNA-binding antibody titers, which fluctuated as the infection progressed. All three species caused kidney damage and dysfunction, as assessed by changes in morphology, blood urea nitrogen, and excreted albumin; this damage correlated with the extent of parasitemia and was observed before the levels of DNA-binding antibodies were detectably elevated in the serum. However, the results of immunohistochemical studies demonstrated that DNA-binding monoclonal antibodies bound ex vivo to glomeruli within kidneys prepared from mice at late stages of infection, after the initial damage had been incurred. Our findings suggest how DNA-binding antibodies could contribute to the kidney pathology associated with both malaria and certain autoimmune diseases, such as systemic lupus erythematosus.
An understanding of the mechanisms by which pathology arises in malaria infections is essential for accurate prognosis and treatment of the disease and also for vaccine design. Such an understanding is of particular importance when we consider the kidney pathology of tropical nephrotic syndrome, which is closely associated with Plasmodium malariae infection and results in very high morbidity and mortality (20) . Infection with most species of malaria organisms is associated with either acute or chronic forms of nephritis, and a number of studies have documented the extent and form of structural and functional changes that occur within the kidneys during human, simian, and rodent malarial infections (11) . However, the factors that contribute to the initiation and progression of kidney pathology have not been fully defined. A major factor appears to be the formation and deposition of immune complexes within the kidneys, and it has been suggested that this results from the high levels of circulating parasite antigen and parasite-specific antibodies that accompany infection. However, the chronic lesions associated with tropical nephrotic syndrome do not resolve upon parasite clearance and the consequent reduction in antigen load and immune complexes (20) . This suggests that other host-related factors (and possibly other groups of antibodies) influence the onset, development, and duration of the nephritis associated with malaria.
The autoimmune disease systemic lupus erythematosus is also associated with severe kidney damage and resulting functional abnormalities. Systemic lupus erythematosus patients often have high circulating titers of antibodies that are reactive with a range of self-components, including singlestranded DNA (ssDNA) and double-stranded DNA (ds-DNA), and in a number of studies workers have examined whether such antibodies play a particular role in the onset and development of nephritis (29, 30) . A of DNA-binding antibodies and nephritis, and the detection of these antibodies within kidney lesions has provided additional evidence that they may contribute to kidney immunopathology in patients with systemic lupus erythematosus (29) . Subsequently, in several studies workers have demonstrated the presence of DNA-binding antibodies in the sera of patients infected with malaria organisms (1, 26, 34) , although in only one of these studies have the authors attempted to correlate titers with the nature and extent of kidney damage (1) . However, all measurements of antibody titers were made at single, random time points of infection, and no assessment was made of how changes in production and localization of the antibodies may relate to the onset and development of kidney damage.
The aim of this study was to gain a greater understanding of the sequential development of nephritis in mice with malaria infections and to define more clearly the role of DNA-binding antibodies in kidney immunopathology. Antibody levels were measured at successive stages of acute and chronic rodent malarial infections, and the findings were related to concurrent changes in kidney structure and function. The ex vivo localization of DNA-binding monoclonal antibodies to kidney sections prepared from malaria-infected mice was assessed in order to determine how these antibodies may contribute to damage mechanisms in malaria and also in other parasitic and autoimmune diseases which result in their production.
MATERIALS AND METHODS
Parasite maintenance and serum and urine collection. We used two acute, lethal strains of murine malaria organisms, Plasmodium yoelii nigeriensis and Plasmodium vinckei vinckei. A chronic, lethal variant of Plasmodium berghei into 6-week-old female LACA outbred mice (Tuck & Sons, Essex, England), and the course of infection was followed by preparing daily tail blood smears. These smears were methanol fixed and Giemsa stained, and percentages of parasitemia were calculated following the examination of 2,000-cell samples in random fields. Preinfection serum samples were obtained by tail bleeding mice at least 1 week prior to infection; this ensured that erythrocyte numbers had returned to normal levels at the time of parasite inoculation. Terminal blood samples were collected by cardiac puncture. Blood was allowed to clot at 37°C for 1 h and then centrifuged at 200 x g for 10 min before serum was removed and stored at -20°C. Urine was collected from individual mice every 24 h (before and after infection) by applying gentle pressure on the bladder.
Enzyme-linked immunosorbent assay for detection of DNAbinding antibodies. Pre-and postinfection samples were tested for the presence of antibodies that bound to ssDNA and dsDNA by using the enzyme-linked immunosorbent assay technique described by Morgan et al. (21) . Briefly, poly-L-lysine-coated plates were coated with 20 ,ug of calf thymus dsDNA per ml in 0.15 M phosphate-buffered saline (PBS) (pH 7.4). The dsDNA was purified by CsCl centrifugation (20 jig/ml) and treated with S1 nuclease (Sigma Ltd., Poole, England) (100 U/mg per ml of DNA solution) for 1 h at 37°C prior to use in coating procedures. ssDNA preparations were made by boiling calf thymus DNA for 10 min and then rapidly cooling the preparation on salted ice before the plates were coated (10 ,g/ml in PBS). Then both antigen preparations were incubated for 1 h at 37°C, and the antigencoated plates were washed thoroughly with PBS. Subsequently, all wells were overlaid with 2% casein in PBS for 1 h at 37°C to prevent nonspecific binding. Tripling dilutions of pre-and postinfection serum samples (1/30 starting dilution in PBS) were added; individual serum samples were tested in duplicate. Negative control wells received only PBS, while positive control wells received tripling dilutions of protein A-purified murine DNA-binding monoclonal antibodies derived from MRL/lpr mice (21) . These antibodies selectively bind to ssDNA or dsDNA (antibodies mAb228 and mAb402, respectively). After 2 h of incubation at 4°C, all of the wells were washed thoroughly with PBS-0.1% Tween 20, and antibody binding was detected by incubation with rabbit anti-mouse immunoglobulin conjugated to horseradish peroxidase for an additional 2 h at 4°C. A substrate solution was then added (1-mg/ml o-phenylenediamine substrate solution and 3% H202 in citrate phosphate buffer). The reaction was stopped by adding 0.5 M citric acid, and the A450 was determined. For each serum sample, a semi-log curve of serum dilution versus optical density values was plotted to obtain a midpoint titer.
Measurement of kidney dysfunction. berghei-infected mice by measuring blood urea nitrogen levels, using the urease-Berthelot reaction, as described previously (8) .
Assessment of immune complex deposition in kidneys. Kidneys were removed from normal and infected mice. These kidneys were placed in OCT compound (British Drug Houses, Poole, England), mounted on cork platforms, snapfrozen in liquid hexane, and suspended in liquid N2. The organs were stored at -80°C until they were required. Sections (thickness, 4 to 5 ,um) were prepared by cryotomy at -15°C, placed on 12-well Multitest slides (Flow Laboratories, Rickmansworth, England), and stored desiccated overnight at room temperature. Immune complex deposition was detected in each section by overlaying the section with a 1/25 dilution of fluorescein-conjugated rabbit anti-mouse immunoglobulin G (IgG) or rabbit anti-mouse C3c (both from Nordic Immunochemicals, Maidenhead, England) in PBS containing 10% normal mouse serum. Control sections were overlaid with PBS containing only normal mouse serum. Following extensive washing in PBS, the sections were overlaid with Citifluor retardant (Citifluor Ltd., London, England) and cover slips prior to examination with a Zeiss U/V microscope.
DNA-binding antibody attachment to kidney sections. Kidney sections were prepared from normal and infected animals as described above. All subsequent incubations were carried out at room temperature under humidified conditions. Three sequential blocking steps were carried out to prevent nonspecific antibody binding; the sections were overlaid with avidin, then with biotin (20 min each step, using a Vectastain kit supplied by Vector Laboratories, Peterborough, England), and finally with 20% fetal calf serum in PBS. The preparations were washed extensively between steps. The sections were then overlaid with a 1/10 dilution of protein A-purified monoclonal antibody mAb228 or mAb4O2 (reactive with ssDNA and dsDNA, respectively). All antibodies were diluted in PBS (pH 7.4) containing 10% normal mouse serum and 1% bovine serum albumin. Then the sections were incubated with a 1/100 dilution of biotinylated rabbit anti-mouse immunoglobulin (Jackson Immunoresearch Laboratories, Stratech Scientific Ltd., Luton, England) for 30 min, followed by 30 min of incubation with a 1/100 dilution of strepavidin-peroxidase complex (Amersham Ltd., Aylesbury, England), and then they were flooded with a peroxidase substrate solution (400 gig of diaminobenzidine per ml in PBS containing 0.02% cobalt chloride, 0.015% nickel ammonium sulfate, and 0.01% H202). Control sections were prepared by selectively omitting the initial blocking steps, the DNA-binding antibodies, the biotinylated rabbit anti-mouse immunoglobulin, or the substrate solution.
All preparations were then counterstained for 10 min in 5% Light Green in distilled water, mounted in DPX (British Drug Houses) and examined for evidence of antibody binding.
Statistical analysis. A Kendall coefficient analysis was (Fig. 3) . In each case, very low titers of DNA-binding antibodies were detected prior to infection. Mice infected with P. vinckei or P.
yoelii nigeriensis exhibited gradual increases in the titers of both ssDNA-and dsDNA-binding antibodies during the middle and late stages of infection. In contrast, infection with P. berghei clone RC resulted in fluctuating titers of ssDNA-binding antibodies, with levels reaching peaks at days 17 and 45; dsDNA-binding antibodies were present at only very low levels throughout. There was a strong correlation between the production of antibodies with ssDNA reactivity and the production of antibodies with dsDNA reactivity, but the serum titers did not appear to relate to the extent of parasitemia in any of the infections studied.
Changes in kidney function during the course of infection. Disturbances in kidney function were demonstrable early in all infections (Fig. la and b and 2a ). Mice infected with P. vinckei or P. yoelii nigeriensis showed increases in urine albumin levels at around day 7, approximately 48 h after the first peak of parasitemia. These levels rose gradually and remained high throughout infection, and normal functioning did not resume before death ( Fig. la and b) . Infection with P. berghei also resulted in initial kidney dysfunction around days 5 to 7, coinciding with the first increase in parasitemia, (Fig. 2a) (Fig. 4A) (Fig. 4C and D) . The dsDNA-binding monoclonal antibody, mAb410, bound to nuctei within the glomeruli and tubules of normal and infected mice (Fig. 4B) , as expected. Thus, the increased glomerular staining observed in sections from infected mice when monoclonal antibody mAb410 was used probably reflects increased hypercellularity, as a result of either localized cell proliferation or cellular influx.
DISCUSSION
All of the murine malarial infections examined in this study were accompanied by the production of ssDNAbinding antibodies. Only the acute infections resulted in increases in the levels of dsDNA-binding antibodies; these increases were very small and were detectable only at the later stages of infection. Overall, our findings are in agreement with the findings of previous studies in which DNAbinding antibody levels were measured in sera from patients infected with human malarial species (1, 4, 26) ; a proportion of each patient group was shown to have significantly increased levels of ssDNA-binding antibodies, while no dsDNA-binding antibodies were detected in any of the patients. In contrast, Zouali and co-workers (34) reported increased titers of dsDNA-binding antibodies in patients infected with acute falciparum malaria organisms. This difference may have arisen from the use of different detection methods; while in earlier studies, workers used Farr assays or Crithidia immunofluorescence, in more recent investigations workers have adopted enzyme-linked immunosorbent assay techniques to facilitate the detection of a greater range of low-and high-affinity antibodies (4, 34) . In addition, the human serum samples analyzed in all of these studies were prepared at single, random time points of infection. Thus, any fluctuations in antibody titers (as observed during P. berghei clone RC infection in this study) would not have been detected.
Increases in DNA-binding antibody titers have also been observed during the course of other parasitic diseases, notably in trypanosomiasis and leprosy (16, 25) and in certain autoimmune diseases (27, 30) . In many cases, increased levels of other autoantibodies which react with ribonuclear proteins and nuclear antigens can be detected (23, 25, 29) . There is only limited information about how such autoantibodies arise in the various animal models of disease, and even less is known of their pathogenic properties. Furthermore, it is not clear that antibodies of ostensibly similar specificity are involved in common pathological processes in the different infections and autoimmune diseases.
There are a number of different ways in which DNAbinding antibodies could arise during infection. First, they may be generated as a result of antigen-driven events. Although DNA is considered to be poorly immunogenic, the extensive cellular and tissue damage resulting from infection could result in the release of DNA or host-parasite antigens, which contain shared epitopes. This is observed in leprosy, in which a component of the bacterial cell wall has been shown to share epitopes with DNA (19) . Second, it is possible that the antibodies arise as a result of extensive somatic mutation of antibodies raised against an unrelated antigen. This was initially demonstrated in antibodies produced by the human T15 myeloma, in which a single amino acid substitution was shown to result in the loss of phosphocholine-binding activity and the acquisition of dsDNA reactivity (7). Finally, it has been suggested that these antibodies arise in malaria patients as a result of polyclonal activation of autoreactive B cells. Such cells can be isolated from normal mice and humans and stimulated in vitro with lipopolysaccharide to produce DNA-binding antibodies (14) . During infection, unidentified malarial antigens may provide this stimulus (9) .
There is considerable evidence which suggests that in autoimmune diseases, many autoreactive B cells belong to a distinct population of lymphocytes, which are strictly controlled and linked through the expression of common idiotypes and express the CD5 surface marker (6) . Such cells produce polyreactive, low-affinity IgM autoantibodies. The pathogenic potential of the different antibodies is not known, but polyreactive antibodies are pathogenic under defined circumstances (22) . It is also unclear whether common idiotypes, such as 16/6, that are found on autoantibodies in patients with lupus (13, 15) and in patients with parasitic infections (31) are expressed by antibodies made by CD5-positive B cells. It is interesting that in this study, the ssDNA-and dsDNA-binding antibodies detected in mice with malaria were present at low levels, and their production appeared to be coregulated. Likewise, a preliminary analysis of DNA-binding monoclonal antibodies prepared from these mice showed that they are predominantly of the IgM subclass (unpublished data). However, Yoshida and colleagues (33) investigated DNA-binding antibody production in mice infected with a nonlethal strain of P. yoelii and detected concurrent increases in the levels of both IgG and IgM antibodies with DNA-binding activity.
The major aim of this study was to determine whether DNA-binding antibodies contribute directly or indirectly to malaria-associated kidney pathology. The results of immunohistochemical studies demonstrated that such antibodies bound to kidneys removed from mice at middle or late stages of infection, suggesting that they may contribute to pathology in vivo, once initial damage has been incurred. It has been suggested that dsDNA-binding antibodies predominantly contribute to associated nephritis in lupus patients. However, in this study we found that ssDNA-binding antibodies may play an equally important role. This observation supports the findings of Lake and Staines (18) , who found that the ssDNA-binding monoclonal antibody used in our (2, 10, 32) , and it has been suggested that this deposition arises from the localization of parasite-specific antibodies to trapped parasite antigen (12) . While our results showed that there was a strong correlation between the onset of kidney damage and initial peaks in blood parasite loads, it is probable that a range of antibodies, with differing specificities, are involved in complex formation and deposition. As mentioned above, all three types of murine malaria infections investigated in this study resulted in rapid changes in glomerular structure. Further studies are being carried out to determine whether this results from cellular infiltration following complement activation.
In conclusion, in this study we demonstrated that DNAbinding antibody production is modulated in mice with acute or chronic malaria infections and that such antibodies contribute to the development of kidney pathology during the later stages of infection. Antibodies binding to ssDNA or dsDNA were localized within the glomeruli of kidneys prepared from mice at middle or late stages of infection, after immune complex deposition and morphological changes had occurred. Further analysis will be required to determine whether these antibodies contribute to the initiation of damage through the in situ formation of complexes and how the properties of these antibodies affect long-term pathogenesis. Ultimately, such studies should provide a greater understanding of the role of DNA-binding antibodies in both the autoimmune diseases and the parasitic diseases in which they arise and a greater understanding of how the production of these antibodies affects the onset and development of disease processes.
